In ₹ Crore except Per Share Latest Annual	INDRAMEDCO FY26	ARTEMISMED FY26	SHALBY FY26	GKSL FY26	Peer Average
Valuation — at last close
P/E	◆ 15.89×	45.42×	37.76×	69.02×	50.73× -69%
P/B	3.94×	5.05×	◆ 1.30×	5.37×	3.91× +1%
EV/EBITDA	◆ 9.95×	25.21×	12.38×	48.88×	28.82× -65%
Market Cap	₹2,918 Cr	₹4,717 Cr	₹1,311 Cr	₹1,355 Cr	₹2,461 Cr +19%
Growth
Revenue CAGR 3Y	10.50%	◆ 13.61%	12.35%	—	12.98% -19%
Revenue CAGR 5Y	19.30%	◆ 21.50%	—	—	21.50% -10%
Net Income CAGR 3Y	28.69%	◆ 39.74%	-19.97%	—	9.89% +190%
Revenue YoY (latest Q)	8.35%	◆ 12.69%	11.74%	—	12.21% -32%
Net Income YoY (latest Q)	8.33%	◆ 48.33%	36.70%	—	42.52% -80%
Profitability
EBITDA Margin	18.00%	17.40%	12.51%	◆ 32.85%	20.92% -14%
Net Income Margin	12.39%	9.59%	3.04%	◆ 20.50%	11.04% +12%
Return on Common Equity	◆ 27.47%	11.69%	3.74%	6.14%	7.19% +282%
Return on Capital Employed	◆ 29.88%	11.88%	5.79%	8.24%	8.64% +246%
Return on Assets	◆ 19.93%	7.45%	1.96%	5.65%	5.02% +297%
Credit & Quality
Total Debt/Equity	◆ 0.00×	0.24×	0.54×	0.06×	0.28× -100%
Interest Coverage	◆ 37.09×	5.06×	1.87×	11.84×	6.26× +493%
Scale — latest FY
Revenue / Total Income	₹1,483 Cr	₹1,081 Cr	₹1,141 Cr	₹82 Cr	₹768 Cr +93%
Net Income	₹184 Cr	₹104 Cr	₹34.7 Cr	₹16.8 Cr	₹51.7 Cr +255%
Total Assets	₹991 Cr	₹1,429 Cr	₹1,839 Cr	₹298 Cr	₹1,188 Cr -17%
EPS	₹20.03	₹6.56	₹3.23	₹2.49	₹4.09 +389%
Book Value per Share	₹80.76	₹59.04	₹93.49	₹32.03	₹61.52 +31%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.